Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124196) titled 'A Prospective, Single-Arm Clinical Study of Neoadjuvant Low-Dose Radiother... Read More
Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124199) titled 'A single-arm, prospective real-world study of trifluridine and tipiracil c... Read More
Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124203) titled 'Mechanistic study of finerenone in delaying the progression of diabetic ki... Read More
Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124206) titled 'A phase II clinical study of adjuvant immunotherapy with or without chemot... Read More
Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124210) titled 'Comparison of Analgesic Efficacy and Safety of Tegileridine and Sufentanil... Read More
Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124214) titled 'A study exploring the immunogenicity and safety of different immunization ... Read More
Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124218) titled 'Comparative study on the effects of vitamin D screening and intervention o... Read More
Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124222) titled 'Develop A Comprehensive Breast Cancer Risk Prediction Model for Chinese Wo... Read More
Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124151) titled 'Application of Multimodal Computational Techniques Based on Developmental ... Read More
Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124154) titled 'Neoadjuvant Chemotherapy Combined with PD-L1/VEGF Bispecific Antibody vers... Read More